Assessment of Health Economics in Alzheimer??s Disease (AHEAD)
- 1 January 2002
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 20 (9) , 629-637
- https://doi.org/10.2165/00019053-200220090-00006
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- GalantamineDrugs, 2000
- The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: A Markov modelClinical Therapeutics, 1999
- Estimating Long Term Cost Savings from Treatment of Alzheimer??s DiseasePharmacoEconomics, 1999
- Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.American Journal of Public Health, 1998
- Costs of dementia and dementia care: a reviewInternational Journal of Geriatric Psychiatry, 1997
- The economic impact of tacrine in the treatment of Alzheimer's diseaseClinical Therapeutics, 1997
- Group-Living Care: An Alternative for the Demented ElderlyDementia and Geriatric Cognitive Disorders, 1997
- A Dynamic Long-Term Care System for the Demented ElderlyInternational Psychogeriatrics, 1996
- Group living for elderly patients with dementia — A cost analysisHealth Policy, 1996
- Cost-Utility Analysis of Group Living in Dementia CareInternational Journal of Technology Assessment in Health Care, 1995